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Immunodiffusion (ID) is the serologic test most frequently used for the diagnosis and posttherapy follow-up
of patients with paracoccidioidomycosis (PCM). The ID test is highly specific (100%), but its sensitivity is
relatively low (90%), leading to false-negative results. The aim of this study was to determine the profiles of
antibodies in sera from patients with proven PCM and with negative results in the ID test (IDneg) versus
positive results in the ID test (IDpos). We analyzed 46 sera from patients with active PCM for total immuno-
globulin G (IgG) and IgG subclass responses to Paracoccidioides brasiliensis gp43 antigen (treated or not
treated with sodium metaperiodate) by enzyme-linked immunosorbent assay and immunoblotting. Immuno-
blotting showed that both IDneg and IDpos sera recognized predominantly the gp43 fraction of the P. brasiliensis
antigen used in the ID test. IDneg sera contain low-avidity antibodies, low levels of specific IgG (total) and IgG1,
and high levels of IgG2 compared with IDpos sera. The antibodies present in IDneg sera were predominantly
directed against carbohydrate epitopes, since treatment with sodium metaperiodate resulted in a significant
decrease in antibody reactivity. These data suggest that the lack of reactivity of sera from PCM patients in the
ID test may be related to the production of low-avidity IgG2 antibodies directed against carbohydrate epitopes.
Paracoccidioidomycosis (PCM) is the most prevalent sys-
temic mycosis in Latin America. The disease, caused by the
dimorphic fungus Paracoccidioides brasiliensis, has multiple
clinical aspects, since the fungus is able to disseminate through
the lymphatic system and bloodstream to any part of the host
organism (6). There are two major clinical forms of PCM:
juvenile form (JF) and adult form (AF). The JF equally affects
young patients of both sexes and is characterized by systemic
lymph node involvement, hepatosplenomegaly, and bone mar-
row dysfunction, thereby resembling a lymphoproliferative dis-
ease. The AF almost always affects adult males, who show a
high frequency of pulmonary, skin, and visceral involvement
(13).
The diagnosis of PCM is made by observation of the char-
acteristic yeast cells in clinical materials (sputum, biopsy spec-
imens, or scrapings of lesions) or cultures. However, due to the
time and material required to perform these techniques, sero-
logic tests have been developed to detect both antibodies (7,
19, 30, 31) and antigens (14, 15, 16, 22). Serologic tests are
important tools when other procedures are not available as
well as for posttherapy follow-up (21). The immunodiffusion
(ID) test is one of the most widely used techniques due to the
simplicity and low costs involved in its execution. The ID test
is highly specific (about 100%), but false-negative results are
not rare due to a sensitivity of 85 to 90% (8, 10, 11).
In a previous study, Mamoni et al. (20) showed that JF
patients produce high levels of antibodies, predominantly IgG4
and IgE. The same profile was observed for AF patients with
disseminated lesions (multifocal adult form), indicating that
immunoglobulin G4 (IgG4) and IgE may be useful markers of
disease severity and impairment of the protective immune re-
sponse. On the other hand, patients with isolated lesions (uni-
focal adult form) produce low levels of antibodies, mainly of
the IgG1 isotype (20). Isotype switching is in part controlled by
cytokines present in the microenvironment where B cells dif-
ferentiate. In fact, lymphocytes from JF patients responding to
P. brasiliensis antigen produce high levels of interleukin 4
(IL-4) and IL-5 and low levels of gamma interferon, whereas
cells from AF patients produce low levels of IL-4 and IL-5 and
high levels of IL-12 (24).
Studies of the physicochemical nature of antigens and the
antibodies that they elicit have revealed a restriction in the
ability of IgG subclasses to be induced by certain antigens. It is
well known that carbohydrate antigens elicit the production of
IgG2 antibodies, whereas antiprotein antibodies are mainly
IgG1, IgG3, and IgG4 (9, 27). A further feature of the humoral
immune response is the avidity of antibody binding, which may
be regarded as an estimate of the average affinity of polyclonal
antibodies for a complex antigen (25). The avidity of antibody-
antigen binding varies greatly according to the time of infec-
tion and the class of antibodies produced (12).
Considering that all of the above-mentioned aspects may
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interfere with the results of a serologic test, in the present
study we analyzed the antibody profiles of sera from patients
with proven PCM and with negative results in the ID test with
respect to isotype composition and avidity.
MATERIALS AND METHODS
Sera. In a previous study, Blotta et al. described a specificity of 100% and a
sensitivity of 87% for ID tests performed (3). For this study, we selected 28
serum samples from IDneg PCM patients and 18 from IDpos PCM patients (9
serum samples from patients with the JF and 9 serum samples from patients with
the AF). The diagnosis was confirmed by histopathological examinations of skin
or of ganglionic or pulmonary biopsy specimens or by the finding of the fungus
in scrapings of skin lesions, in material obtained from lymph nodes, or in sputum
(direct examination). All 28 IDneg serum samples were from patients with the
unifocal (pulmonary) AF of the disease.
ID test. The ID test was performed with a crude P. brasiliensis exoantigen as
previously described (8).
Preparation of CFA. P. brasiliensis B-339 was grown on Sabouraud glucose
agar at 35°C for 3 days. The fungal growth from three randomly selected tubes
(about 300 mg [wet weight]) was collected by gently scraping the surface. The cell
mass was suspended in 1 ml of 0.15 M phosphate-buffered saline (PBS) (pH 7.4),
mixed for 30 s in a Vortex mixer, and immediately centrifuged at 10,000  g in
an Eppendorf tabletop centrifuge for 60 s. The resulting supernatant fluid con-
tained cell-free antigen (CFA). The protein concentration in CFA was deter-
mined by the method of Bradford (5).
Preparation of P. brasiliensis gp43 antigen. Purified gp43 was obtained by
affinity chromatography of the crude exoantigen of P. brasiliensis B-339 on
Affigel-10 (Bio-Rad, Hercules, Calif.) coupled with anti-gp43 monoclonal anti-
body (7). gp43 was eluted from the column with 0.1 M glycine-HCl (pH 2.8),
immediately neutralized with 2 M Tris (pH 9.0), concentrated in an Amicon 10K
apparatus, and analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE). The protein content was measured by the method of
Bradford (5).
SDS-PAGE. Crude exoantigen or CFA obtained as described above was mixed
with reducing sample buffer, containing 62.5 mM Tris-HCl (pH 6.8), 2% SDS,
10% glycerol, 10% 2-mercaptoethanol, and 0.05% bromophenol blue. The
polypeptides were separated by SDS-PAGE on 10% acrylamide gels in a Mini
Protean II apparatus (Bio-Rad). Protein standards (Sigma, St. Louis, Mo.) with
the following molecular masses were used: triosephosphate isomerase, 26.6 kDa;
lactic dehydrogenase, 36.5 kDa; ovalbumin, 45 kDa; pyruvate kinase, 58 kDa;
fructose-6-phosphate kinase, 84 kDa; and -galactosidase, 116 kDa.
Immunoblotting for IgG and IgG subclasses. Immunoblotting was performed
as previously described (2), with a few modifications. Briefly, after electrophore-
sis, proteins were transferred to nitrocellulose paper (NCP) by using a Mini
Trans-Blot transfer cell (Bio-Rad). Prior to immunological staining, the free sites
on the NCP were blocked with 5% nonfat milk in Tris-buffered saline containing
0.1% bovine serum albumin (BSA) and 0.05% Tween 20 (TBS-BSA-T) (pH 7.3)
for 2 h at room temperature. The NCP was sliced vertically, and the strips were
incubated individually for 1 h at room temperature with sera obtained from
patients and diluted 1:200 in TBS-BSA-T. The strips were washed six times for
10 min each time with TBS-BSA-T and then incubated with peroxidase– anti-
human IgG (1:1,000 dilution) (A-8667; Sigma) in TBS-BSA-T for 1 h. The strips
were washed again and incubated with the substrate (3,3-diaminobenzidine 
4HCl [Sigma] at 0.5 mg/ml and 10 l of H2O2 in PBS). After color development,
the strips were rinsed extensively with distilled water.
For the IgG subclass determination, after incubation with sera diluted 1:50 for
2 h, the strips were washed as described above. Then, antisubclass antibodies
(anti-human IgG1 [I9388], IgG2 [I5635], IgG3 [I9763], or IgG4 [I9888]; Sigma)
diluted 1:2,000 were added. After 1 h of incubation at 37°C, the strips were
washed. Then, sheep anti-mouse IgG– peroxidase (1:1,000 dilution) (A6782;
Sigma) was added. The subsequent steps were the same as those described for
IgG.
ELISA for the determination of specific IgG. For the IgG enzyme-linked
immunosorbent assay (ELISA), 96-well plates (Greiner, Kremsmu¨nster, Austria)
were coated with P. brasiliensis gp43 at 2 g/ml. The assays were performed as
described previously (20). The samples were run in duplicate. The cutoff was
determined to be the mean plus 2 standard deviations of the absorbance ob-
tained with sera from 23 healthy individuals. Samples were considered positive
when the absorbances were higher than 0.320 at a 1:800 serum dilution. The IgG
titer was established as the highest dilution of serum with an absorbance higher
than the cutoff.
ELISAs for the determination of IgG subclasses. Ninety-six-well plates were
coated with P. brasiliensis gp43 at 2 g/ml in 0.1 M carbonate buffer (pH 9.6)
overnight at 4°C. The plates were washed with PBS– 0.05% Tween 20 (PBS-T).
The remaining binding sites were blocked with PBS-T– 5% nonfat dry milk for
2 h at 37°C. After three washes with PBS-T, serum samples (1:50 dilution) were
added in duplicate, and the plates were incubated for 2 h at 37°C. The wells were
washed as described above, and antisubclass antibodies (anti-human IgG1, IgG2,
IgG3, or IgG4; Sigma) were added. After 1 h of incubation at 37°C, the plates
were washed again, and sheep anti-mouse IgG– peroxidase (1:1,000 dilution) was
added. After 1 h of incubation at 37°C and three washes with PBS-T, the
substrate solution (o-phenylenediamine in 0.1 M citrate-phosphate buffer [pH
5.0] and 10 l of 30% H2O2) was added, and the reaction was stopped by the
addition of 2 N H2SO4. The optical densities (ODs) were read with an ELISA
reader (SLT Spectra; SLT Instruments, Salzburg, Austria) at 492 nm. Results
were expressed as the absorbance index (AI), a numerical value calculated by
dividing the net absorbance of each test serum sample by the net absorbance of
a positive reference serum pool on each plate and multiplying the resulting value
by 100. The AI is an arbitrary value that is linearly related to the antibody
concentration and allows the comparison of sera tested on different plates and in
different experiments (20). The reference serum pool was composed of a mixture
of four sera: two from JF and two from AF patients with PCM. The same pool
was used throughout the study.
Treatment of gp43 with sodium metaperiodate. The treatment of gp43 with
sodium metaperiodate was previously described by Puccia et al. (26), who
showed the elimination of cross-reactions with samples from patients with other
mycoses due to the removal of periodate-sensitive carbohydrate epitopes con-
taining galactosyl residues. After overnight coating with gp43 (2 g/ml) at 4°C,
half of the ELISA plate was treated with 40 mM sodium metaperiodate in 1 M
citrate buffer (pH 4.5) for 30 min in the dark. Individual serum samples were
added to the corresponding wells on both the metaperiodate-treated and the
untreated halves of the plate. The subsequent steps were the same as those
described above. The titers of the samples were determined, and the decrease in
the absorbance of metaperiodate-treated samples was calculated by dividing the
result for the metaperiodate-treated well by the result for the untreated well and
multiplying the resulting value by 100.
Determination of avidity of anti-gp43 antibodies. The avidity of anti-gp43
antibodies was estimated from their capacity to remain bound to the antigen in
the presence of 6.0 M urea and was measured as described by Jenum et al. (17).
Each serum sample was analyzed in a twofold dilution range (rows A and B,
starting at 1:200). After incubation, row A was washed with PBS-T containing 6
M urea, whereas row B was washed with washing solution not containing urea.
The subsequent steps of the reaction were the same as those of the standard
ELISA. For each serum sample, two end-point titers (rows A and B) were
calculated with the following formula: titer dilutionx1  10n; in this equation,
dilutionx is the highest dilution giving an OD of 0.32 (cutoff) and n is equal to
log2  [(ODx  0.32)/(ODx ODy)], where ODx is the OD at dilutionx and ODy
is the OD at the next higher dilution from dilutionx. The IgG avidity was
calculated with the following formula: avidity  (titer in row A/titer in row B) 
100.
Statistical methods. The nonparametric Mann-Whitney or Kruskal-Wallis test
was used to compare the variables between groups, and the nonparametric
Wilcoxon test was used to compare the response of antibodies against the
metaperiodate-treated antigen to that of antibodies against the untreated anti-
gen. Significance was defined as a P value of 0.05.
RESULTS
In ELISAs with gp43 from P. brasiliensis as the antigen, sera
from IDneg patients were positive, although they had lower IgG
titers than IDpos sera. Interestingly, when sera were tested with
gp43 treated with sodium metaperiodate, the absorbance val-
ues of IDneg sera dropped significantly, reaching ODs below
the cutoff (0.320). On the other hand, IDpos sera, although
showing a significant decrease in absorbance values, main-
tained ODs above the cutoff (Fig. 1).
Sodium metaperiodate oxidizes carbohydrate epitopes, re-
ducing the binding of antibodies directed against this portion
of proteins. As IgG2 is preferentially produced against carbo-
hydrate antigens, we decided to verify the profiles of IgG
subclasses produced by the IDneg patients. As shown in Fig. 2,
VOL. 10, 2003 NEGATIVE IMMUNODIFFUSION TESTS IN PCM 803
IDneg patients predominantly produced IgG2 antibodies
against gp43, whereas IDpos patients produced more IgG1 (AF
patients) or IgG2 and IgG4 (JF patients).
When the IgG ELISA was performed with gp43 treated with
sodium metaperiodate, we observed a large decrease in the
absorbance values of the IDneg sera. Furthermore, the ELISAs
for subclasses showed a decrease in IgG2 absorbance values in
IDneg and AF (IDpos) patients, supporting the anticarbohy-
drate nature of these antibodies. Interestingly, besides the de-
crease in IgG2 reactivity, IDneg sera showed a remarkable
decrease in IgG1 reactivity compared with the other groups
(Table 1).
To determine whether the differences in the subclass re-
sponses measured by ELISAs were due to differences in the
antigen fraction recognized, we examined the antibody re-
sponse to a P. brasiliensis crude antigen or CFA. Western blot
analysis revealed the same band patterns for all groups (Fig.
3a). The subclass immunoblots showed the same patterns of
subclass distribution as those observed in the ELISAs, with all
sera recognizing mainly the 43-kDa fraction (Fig. 3b).
Additionally, IDpos and IDneg sera were tested for antibody
avidity, since low avidity could be involved in a lack of reac-
tivity in ID tests. We observed that the antibodies in IDneg sera
had a lower avidity than those in IDpos sera (Fig. 4).
DISCUSSION
ID is the most widely used serologic test for the diagnosis
and follow-up of treatment of PCM. However, despite its low
cost and simplicity, several studies have demonstrated the oc-
currence of false-negative results with this method (8, 10, 11).
Differences in the profiles of antibodies produced by pa-
tients with the JF and AF of PCM were previously described
(20). IDneg patients, although presenting clinical symptoms of
the AF of PCM, predominantly produce IgG2 against P. bra-
siliensis gp43, whereas IDpos patients produce mainly IgG1.
gp43 is a glycoprotein of 43,000 Da that can be purified from
the supernatant fluid of yeast cell cultures by affinity chroma-
tography. This molecule specifically binds to the extracellular
matrix protein laminin, influencing pathogenesis (18, 32).
Moreover, gp43 is the immunodominant antigen in PCM, be-
ing recognized by almost all sera from patients with the disease
(2).
The most interesting result obtained in the present study was
FIG. 1. Metaperiodate-treated (MT) or untreated (UT) anti-gp43
IgG in IDneg and IDpos sera. Results are expressed as the absorbance
at a 1:800 dilution. The horizontal bars represent the median, and the
dotted line represents the cutoff (0.320). For the Wilcoxon test of UT
IDneg versus MT IDneg sera, the P value was 	0.0001; for UT IDpos
versus MT IDpos sera, the P value was 	0.0001.
FIG. 2. Levels of anti-P. brasiliensis gp43 IgG1, IgG2, IgG3, and IgG4 in sera from IDneg patients and IDpos patients (AF and JF of PCM).
Results are expressed as the AI. The horizontal bars in the boxes represent the median, and the error bars represent the standard deviations.
TABLE 1. Effect of P. brasiliensis gp43 treatment with sodium
metaperiodate on ELISA resultsa
Serum sample
% Decrease in absorbance or AI for:
Total IgG IgG1 IgG2 IgG3 IgG4
IDneg 56b 56b 63c 42 25
IDpos
AF 15 21 51c 26 22
JF 15 24 23 34 9
a Assays were performed with serum samples from IDneg patients and IDpos
patients (AF and JF of PCM). The data represent the decrease in the absorbance
at a 1:800 dilution (OD at 492 nm) for total IgG and the AI for IgG subclasses
after treatment of P. brasiliensis gp43 with sodium metaperiodate.
b The P value was 0.05 for a comparison with the AF or JF group.
c The P value was 0.05 for a comparison with the JF group.
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that antibodies produced by IDneg patients were predomi-
nantly directed against carbohydrate epitopes, since the treat-
ment of gp43 with sodium metaperiodate resulted in a signif-
icant decrease in absorbance in the IgG ELISA. Periodate
treatment can be used to identify antibody responses directed
against carbohydrate-containing epitopes on various glycocon-
jugates by associating the oxidation of vicinal hydroxyl groups
on sugars with dialdehydes, causing a loss of antibody recog-
nition (4, 23).
It is known that IgG2 antibodies are preferentially directed
against carbohydrate antigens, a fact confirmed here by the
observation of the decrease in the reactivity of these antibodies
against sodium metaperiodate-treated gp43. In IDpos sera from
AF patients, a marked decrease in IgG2 but not in IgG1 levels
was observed after this treatment. As a result, the total IgG
ELISA values did not drop significantly, since IgG1 is predom-
inant in these sera. In IDpos sera from JF patients, the levels of
IgG2 were similar to those in IDneg sera; however, the decrease
in reactivity after metaperiodate treatment was small, indicat-
ing that IgG2 antibodies were probably directed against non-
carbohydrate epitopes. On the other hand, in IDneg sera, all
IgG subclasses (IgG1 in particular) showed reduced reactivity
FIG. 3. Antibody response to a P. brasiliensis crude antigen or CFA. (a) Lane 1, SDS-PAGE of P. brasiliensis CFA (silver stain); lanes 2 and
3, IgG immunoblot of representative IDneg and IDpos sera. (b) Top: IgG subclass immunoblots of a representative serum sample from one patient
in each group: 1, AF PCM; 2, JF PCM; and 3, IDneg. Bottom: respective ELISA results expressed as the AI.
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against sodium-metaperiodate treated gp43, indicating that
these sera produce antibodies predominantly directed against
carbohydrate epitopes. Additionally, since IDneg sera did not
react in ID tests but did react in ELISAs, it is possible that the
carbohydrate epitopes in the gp43 molecule are exposed more
when the antigen is coupled to a solid phase, whereas in solu-
tion they are unavailable for antibody binding (28).
Antigen treatment with sodium metaperiodate was previ-
ously used to improve the specificity of serologic tests for the
diagnosis of several diseases, such as histoplasmosis (33), schis-
tosomiasis (23), and PCM (30). The treatment of gp43 with
sodium metaperiodate or the use of deglycosylated gp43 abol-
ishes the cross-reactions caused by sera from patients with
other systemic mycoses, such as hystoplasmosis or Jorge Lo-
bos’ disease, in ELISAs (26, 31), since the carbohydrate motifs
of gp43 are shared by numerous microorganisms. In the
present study, sodium metaperiodate treatment was also able
to abolish the cross-reactions caused by sera from patients with
other pathologies (data not shown). These findings confirm the
importance of the carbohydrate epitopes of gp43, which were
responsible for the cross-reactions observed in the ELISAs.
We also analyzed the avidity of antibodies in both groups,
since it is known that low-avidity antibodies may interfere with
ID tests. We found that IDneg sera had a lower avidity than
IDpos sera. As a rule, low-avidity antibodies predominate dur-
ing acute-phase infection, whereas high-avidity ones are pro-
duced later (1, 25). PCM is a long-term chronic disease in
which patients are constantly exposed to fungal antigens. In
view of this fact, the presence of low-avidity antibodies in
patients with PCM was unexpected but was explained by the
predominance of IgG2. Low-avidity IgG2 has been described
for malaria and other infections (12, 29).
In conclusion, we observed that the lack of reactivity in ID
tests of sera from patients with proven PCM may be related to
the production of low titers of low-avidity IgG2 antibodies
directed against carbohydrate epitopes. To avoid this problem,
some authors have proposed the combined use of techniques
with high specificities, such as ID, and with high sensitivities,
such as ELISAs, with cross-reactions being abolished by the
use of antigens treated with sodium metaperiodate or in a
deglycosylated form (26, 31). However, our results showed that
for some patients who preferentially produce low-avidity an-
ti-P. brasiliensis IgG2 (IDneg patients), sodium metaperiodate
treatment also abolishes reactivity in ELISAs, thus impairing
assay sensitivity.
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